SoCal Taiwanese Biotechnology Association - SoCal TBA

SoCal Taiwanese Biotechnology Association - SoCal TBA SoCal TBA SoCal TBA, a 501(c)(3) organization, thrives to bridge the industrial and academic talents in U.S. and Asia in bio-med fields.

Science, Technology & Engineering

從科學發現、技術開發，到募資、團隊建立與市場拓展，打造生技公司的每一步都充滿挑戰。而對許多具有台灣背景的專業人才而言，更重要的問題是：如何在美國建立自己的職涯與影響力？今年 SoCal TBA 10th Anniversary Sympos...
06/09/2026

從科學發現、技術開發，到募資、團隊建立與市場拓展，打造生技公司的每一步都充滿挑戰。而對許多具有台灣背景的專業人才而言，更重要的問題是：

如何在美國建立自己的職涯與影響力？

今年 SoCal TBA 10th Anniversary Symposium 的 Founder Panel，我們邀請兩位橫跨台美生技產業的重要領袖，分享他們如何把科學創新轉化為企業價值，並在全球市場中創造機會。

🎤 Diane Tang-Liu, PhD, FAAPS, FCP
Co-Founder, President & CEO, AiViva BioPharma
擁有超過 35 年國際藥廠與生技產業經驗，曾共同創辦台灣生技公司，並領導多項新藥從研發走向臨床與商業化。她將分享跨國創業、企業領導，以及如何在全球生技市場建立競爭優勢。

🎤 Francesco Cutrale, PhD
Co-Founder & CTO, Kulia Labs
工程師、科學家與連續創業家，長期投入醫學影像與生物科技創新。從實驗室技術到產品開發，他親身經歷創業初期最真實的挑戰，也將分享新世代創業者如何在台美之間建立合作與成長機會。

Panel Discussion
Founders Talk: Building Careers, Companies, and Cross-Border Opportunity Across Taiwan and the U.S.

無論你是學生、研究人員、產業專業人士，或正考慮未來的創業道路，這場討論都將帶來第一手的經驗與啟發。

距報名截止（6/14） #剩5天 👉 ＃活動連結請見留言區

How do you build a career — and a company — in a country that wasn't where you started?

That's the question at the center of this year's Founders Talk panel.

🎤 Diane Tang-Liu, PhD, FAAPS, FCP Co-Founder, President & CEO, AiViva BioPharma 35+ years across international pharma and biotech — from senior leadership at Allergan to co-founding Allgenesis in Taiwan to building AiViva. She's lived the cross-border path from the inside.

🎤 Francesco Cutrale, PhD Co-Founder & CTO, Kulia Labs Engineer, scientist, serial founder — Lena Labs, Scopulus Optics, now Kulia Labs. He's built across Taiwan, Hong Kong, and the U.S., and knows what the early-stage grind really looks like.

Panel: Founders Talk: Building Careers, Companies, and Cross-Border Opportunity Across Taiwan and the U.S.

📅 June 21 · UCLA CNSI
to register (closes June 14).



當降低藥價的政策也讓新藥開發變得更困難，我們該如何取得平衡？🤔今年 SoCal TBA 年會專題座談： 《The Innovation Paradox: How Policies Designed To Lower Drug Prices ...
06/04/2026

當降低藥價的政策也讓新藥開發變得更困難，我們該如何取得平衡？🤔

今年 SoCal TBA 年會專題座談： 《The Innovation Paradox: How Policies Designed To Lower Drug Prices May Produce Fewer Drugs》 三位來自經濟、法律與智慧財產權領域的講者，一同探討這個複雜議題。

🎤 Erik Hille
Vice President, Modeling & Analytics, Medical Decision Modeling
Erik 擁有超過二十年的健康經濟與醫療分析經驗。
從生物學背景出發，進一步取得經濟學博士學位，目前專注於藥物經濟模型與治療價值評估，協助製藥公司分析新藥在臨床與商業上的影響。他的工作直接影響產業如何評估一項創新的價值。

🎤 Kat MyHao Hille
Attorney, Hille Firm
Kat 專精於生命科學領域的企業交易、臨床資料隱私等相關法務。
她曾參與研究合作、臨床開發、製造、授權及政府合約等多項跨部門專案，也擁有國際商務法律背景。在全球化的新藥開發環境中，她的專業協助企業在法規與商業需求之間取得平衡。

🎤 Aerie Lin
Associate Director, Patent Counsel, Insmed
Aerie 擁有分子神經生物學博士背景，並從學術研究轉入智慧財產與專利領域。

目前負責生技產品的專利策略與商業規劃，協助企業在快速變動的市場與募資環境中，建立具有競爭力與彈性的 IP 佈局。他的經歷也展現了生命科學人才在產業中的多元發展可能。

一起來聽聽專家們的意見，我們 6/21 UCLA 見！ 6/14 報名截止，連結請看留言區 👇

What happens when policies designed to lower drug prices also reduce the incentive to develop new ones?

SoCal TBA 2026 Annual Symposium panel: The Innovation Paradox: How Policies Designed To Lower Drug Prices May Produce Fewer Drugs

🎤 Erik Hille｜VP, Modeling & Analytics, Medical Decision Modeling 20+ years in health economics and data analytics, specializing in pharmacoeconomic modeling and drug value assessment across global markets.

🎤 Kat MyHao Hille｜Attorney, Hille Firm Life sciences transactions and clinical data privacy, with experience supporting biotech companies and international law firms across the U.S., Europe, and Asia.

🎤 Aerie Lin｜Associate Director, Patent Counsel, Insmed From molecular neurobiology researcher to patent attorney — now leading IP and commercial strategy for biopharmaceutical programs at Insmed.

Come hear what the experts have to say.
See you at UCLA on June 21! Registration closes June 14. Link in comments 👇

🎉 SoCalTBA 十週年，我們準備了一個小驚喜！過去十年，SoCalTBA 匯聚了南加州的學者，研究人員、生技專業人士、創業者與學生，一起打造了這個特別的社群。這次，我們特別推出了限量版 SoCalTBA tote bag ，作為捐款支...
06/02/2026

🎉 SoCalTBA 十週年，我們準備了一個小驚喜！

過去十年，SoCalTBA 匯聚了南加州的學者，研究人員、生技專業人士、創業者與學生，一起打造了這個特別的社群。
這次，我們特別推出了限量版 SoCalTBA tote bag ，作為捐款支持我們的感謝禮。

✨ 數量有限，送完為止
📍 可於年會現場領取 (6/21, UCLA CNSI)


🎉 Celebrating 10 Years of SoCalTBA, and We Have a Little Surprise for You!

For the past decade, SoCalTBA has united researchers, biotech professionals, entrepreneurs, students, and innovators across Southern California. Together, we've built something truly special.

To mark our 10th Anniversary, we're introducing a limited-edition SoCalTBA tote bag — a small token of appreciation for those who support the 2026 Annual Symposium.

✨ Available while supplies last
📍 Pick up at the Annual Symposium (6/21, UCLA CNSI)


05/29/2026

想從幕後參與 2026 SoCal TBA 第 10 週年年會嗎？

我們正在招募 On-site Volunteer，一起打造這場最重要的年度盛事。

身為志工，你將在活動前一天協助場地佈置，並在年會當天參與現場運作，與講者、工作人員和所有參與者近距離互動。

確認加入後，可獲得專屬優惠碼。

📌 兩天都需要到場，請先確認：
6/20（週六）下午 2:00–6:00 PM 場佈
6/21（週日）年會當天現場

兩天都可以？
在留言區留下 VOLUNTEER，我們會私訊你優惠碼。👇

Want to be part of the team that makes it happen?

We're looking for on-site volunteers for the 2026 SoCal TBA Annual Symposium — our 10th Anniversary edition. It's a chance to go behind the scenes on our biggest days, work alongside the organizing team, and meet speakers and attendees up close.

📌 Please confirm you're available for both:
Venue setup: June 20 (Saturday), 2:00–6:00 PM
On-site support: June 21 (Sunday), day of the event

Good for both dates?
Comment VOLUNTEER below and we'll DM you your promo code. 👇

🍽️ 邀請參加年會晚餐2026 SoCal TBA 年會當晚，我們將在原場地舉辦 Networking Dinner，邀請講者、業界人士、創業者、投資人與所有參與者，在更輕鬆的環境中延續白天的交流與對話。無論你是想： 🔹 拓展 biotec...
05/28/2026

🍽️ 邀請參加年會晚餐

2026 SoCal TBA 年會當晚，我們將在原場地舉辦 Networking Dinner，邀請講者、業界人士、創業者、投資人與所有參與者，在更輕鬆的環境中延續白天的交流與對話。

無論你是想：
🔹 拓展 biotech / pharma 人脈
🔹 與講者近距離交流
🔹 認識南加州生技社群
🔹 與老朋友相聚、認識新朋友

都歡迎加入我們！

🕡 6 月 21 日（週日）晚上 6:30
📍 UCLA CNSI，Los Angeles
🎟️ $45 | 需加購。

晚餐票可獨立購買，不需參加白天年會也可報名。報名年會時記得在
同一頁面加選 Dinner 票；已買年會票的朋友可加購。

名額有限，立即報名 →

🍽️ The conversations continue beyond the symposium.
Join us for the Evening Networking Dinner following the 2026 SoCal TBA Symposium — an opportunity to connect with speakers, biotech professionals, founders, investors, and fellow attendees in a more relaxed setting.

Whether you're looking to:
• Expand your biotech and pharma network
• Connect with speakers and industry professionals
• Meet the Southern California biotech community
• Reconnect with old friends and build new connections

We would love to have you join us for the evening.
🕡 Dinner begins at 6:30 PM
📍 UCLA CNSI, Los Angeles
🎟️ Separate ticket required
⚠️ Limited seating available

Dinner is a separate ticket from the symposium, and you don't need a symposium ticket to come. If you're doing both, register for each independently.

Learn more & register→

🔊 2026 SoCal TBA年會議程公布。今年的議程涵蓋 AI 生醫應用、轉譯研究、台美跨境創業、藥價政策辯論與職涯溝通技能。兩場 Keynote 由 €500M+ 跨大西洋創業家 Marianne van der Steen, Ph....
05/26/2026

🔊 2026 SoCal TBA年會議程公布。

今年的議程涵蓋 AI 生醫應用、轉譯研究、台美跨境創業、藥價政策辯論與職涯溝通技能。

兩場 Keynote 由 €500M+ 跨大西洋創業家 Marianne van der Steen, Ph.D. 與 25 年 AI × Precision Medicine 投資經驗的 Dr. Chris Yoo（Xcellerant Ventures GP） 主講，午餐圓桌特別邀請生技二姐 Hsiao-Ling Hung, Ph.D., RAC 擔任 Special Guest，與講者們一起跟參加者近距離交流。陣容堅強，機會難得。

年會資訊：June 21 | UCLA CNSI, Los Angeles

報名將於 6/14 截止。

儘速報名 👉

🔊The 2026 SoCal TBA Annual Symposium Agenda is LIVE.

This year's theme is From Foundations to Frontiers: AI, Innovation, and the Future of Biomedicine — covering AI in biomedicine, translational research, cross-border careers between Taiwan and the U.S., drug pricing policy, and communication skills for career growth.

Two keynotes anchor the day: Marianne van der Steen, Ph.D. (Hummingbird Biomedical / Mayo Clinic Campus), who has raised over €500M across life sciences ventures, and Dr. Chris Yoo (Xcellerant Ventures GP), with 25+ years at the intersection of AI, therapeutics, and biotech investment. Lunch runs as speaker-hosted tables — you choose whose table you sit at. Joining as special guest: Hsiao-Ling Hung, Ph.D., RAC (生技二姐), President of TAAB.

June 21 | UCLA CNSI, Los Angeles

Registration closes June 14.

Sign Up Today 🔗

[十週年年會] AI 正在快速改變醫療與生技產業。除了收集更多資料，真正重要的是如何把龐大的健康數據，轉化成能幫助研究、臨床決策與個人化醫療的實際行動。今年 SoCal TBA 十週年年會的 panel session：From Healt...
05/21/2026

[十週年年會] AI 正在快速改變醫療與生技產業。

除了收集更多資料，真正重要的是如何把龐大的健康數據，轉化成能幫助研究、臨床決策與個人化醫療的實際行動。

今年 SoCal TBA 十週年年會的 panel session：
From Health Data to Action: AI Across Devices, Insights, and Personalized Care

將集結四位來自神經科技、數位健康、AI 藥物研發與計算生物學領域的專家，分享 AI 如何重新定義未來醫療。

❇️ Yao-Chuan Chang｜Principal System Engineer at Synchron
專注於新世代腦機介面（BCI）醫療裝置開發，推動神經科技與臨床應用整合。

❇️ Sheng-Hsiou (Shawn) Hsu｜CTO at Kura Care Inc.
運用生成式 AI 與機器學習，打造個人化數位健康平台。

❇️ Chien-Cheng (Mike) Shih｜Data Scientist at Novartis
以 AI 與電腦視覺技術加速影像分析、表型篩選與藥物研發。

❇️ Yi Hsiang Hsu｜VP at ProFound Therapeutics
帶領多體學、人類遺傳學與 AI 團隊，推動精準醫療與生物標記開發。

這場 panel 將深入探討：
🔹 AI 如何整合跨領域生醫資料
🔹 從裝置、影像到基因體資料的實際應用
🔹 個人化醫療與精準醫療的未來方向
🔹 AI 如何改變藥物開發與臨床研究流程

如果你對 AI、生技、數位健康、精準醫療或未來醫療趨勢有興趣，這場討論不要錯過。

🎟 報名將於 6/14截止， #連結在留言區 👇

AI is rapidly transforming how we discover, interpret, and apply health data across the biomedical ecosystem.

At the SoCal TBA 10th Anniversary Symposium, our panel
“From Health Data to Action: AI Across Devices, Insights, and Personalized Care” brings together leaders working at the intersection of neurotechnology, digital health, AI-driven drug discovery, and computational biology.

Featured speakers include:

❇️ Yao-Chuan Chang, Principal System Engineer at Synchron
Leading the architecture, integration, and verification of next-generation Brain-Computer Interface medical devices. With over 15 years of experience in biomedical engineering, neurostimulation, and neuroscience, he has worked across the central, peripheral, and retinal nervous systems. Before Synchron, he served as a Senior Biomedical/Neural Engineer at Medtronic and as a Staff Scientist at The Feinstein Institutes.

❇️ Sheng-Hsiou (Shawn) Hsu, CTO at Kura Care Inc.
Leading the development of a generative AI and machine learning platform for personalized digital health. He began his career at Google X, was a founding member of neurotechnology startup NextSense, and later served as Director of Data Science at Arctop, advancing brain-computer interfaces and human-AI interaction. Outside of his core work, he mentors others through career coaching and remains passionate about how humans and AI can collaborate more effectively.

❇️ Chien-Cheng (Mike) Shih, Data Scientist at Novartis
Applying AI and computer vision to drug discovery across data modalities from cellular to medical imaging. He works closely with biologists and chemists to translate experimental questions into machine learning workflows, with a focus on phenotypic screening and image-based assays. Previously, he was a research scientist in image informatics at Washington University's Center for Cellular Imaging.

❇️ Yi Hsiang Hsu, VP at ProFound Therapeutics
Applying AI, statistical methods, and bioinformatics to drug target and biomarker discovery, as well as clinical trial design and patient stratification across multiple disease areas, including oncology, autoimmune, inflammatory, and cardiometabolic disorders. Previously, he held academic and program leadership roles at Harvard Medical School, the Marcus Institute for Aging Research, and the Broad Institute of MIT and Harvard, with over 15 years of experience spanning translational genomics and computational biology.

Together, they’ll explore how AI is reshaping biomedical decision-making — from devices and imaging to genomics, clinical insights, and personalized care.

If you're interested in AI, biotech, digital health, or the future of precision medicine, this is a conversation you won’t want to miss.

🎟 Registration closes June 14. 👇

退休生技二姐在美國 要來南加了 🎉二姐 (洪筱玲博士) 的轉職經歷相信各位都不陌生，從學術工作一路變成法規專家，一路走進全球製藥產業，最後成為深耕新藥開發與法規策略的專家。她擁有近三十年的生技製藥研發與法規經驗，曾任 Ambrx Biop...
05/19/2026

退休生技二姐在美國 要來南加了 🎉

二姐 (洪筱玲博士) 的轉職經歷相信各位都不陌生，從學術工作一路變成法規專家，一路走進全球製藥產業，最後成為深耕新藥開發與法規策略的專家。

她擁有近三十年的生技製藥研發與法規經驗，曾任 Ambrx Biopharma 法規事務與品質保證（Quality Assurance) 資深副總裁，也曾在 Bristol Myers Squibb 與 Johnson & Johnson 擔任重要法規領導職位，參與多項藥物開發計畫的全球法規策略。

現在的二姐是製藥法規顧問，協助美國與台灣的生技製藥公司規劃產品開發、法規路徑與授權合作機會。從 scientist 到 regulatory strategist 的轉型，也讓她特別理解生技人在不同職涯階段會遇到的選擇與挑戰。

除了專業領域的成就，二姐也長期投入台美生技社群與人才培育，目前擔任 Taiwanese American Biotech Association（TABA）會長，持續陪伴與支持下一代生技人才。

這次很高興邀請到二姐來到年會，她將在SoCal TBA 年會上和大家分享她在生技製藥、法規策略與職涯轉型上的第一手經驗。

📅 UCLA CNSI · 6月21日
🎟 早鳥票 ，5/20截止，只剩最後一天，還沒報名的朋友趕快

報名連結在留言區。

Many of you may already know Dr. Hsiao-Ling Hung’s inspiring career journey — from academic research to regulatory affairs, and eventually into the global pharmaceutical industry as an expert in drug development and regulatory strategy.

Dr. Hsiao-Ling Hung has nearly three decades of experience in biotech and pharmaceutical R&D. She previously served as Senior Vice President of Regulatory Affairs and Quality Assurance at Ambrx Biopharma, and held key regulatory leadership roles at Bristol Myers Squibb and Johnson & Johnson, where she contributed to global regulatory strategies for multiple drug development programs.

Today, Dr. Hung is a pharmaceutical regulatory consultant, advising biotech and pharmaceutical companies in the U.S. and Taiwan on product development, regulatory pathways, and licensing opportunities. Her transition from scientist to regulatory strategist gives her a unique perspective on the choices and challenges biotech professionals face at different stages of their careers.

Beyond her professional achievements, Dr. Hung has long been dedicated to supporting the Taiwanese American biotech community and mentoring the next generation of biotech professionals. She currently serves as President of the Taiwanese American Biotech Association (TABA).

We are excited to welcome Dr. Hung to Southern California! On June 21, she will join us at the SoCal TBA Annual Symposium to share her first-hand insights on biotech/pharma, regulatory strategy, and career transition.

📅 UCLA CNSI · June 21
🎟 Early bird tickets end on May 20 — only one day left!

Don’t miss this opportunity to join us.
Registration link in the comments.

What does it take to build something that reaches patients —not just work in the lab?That's the question Dr. Marianne va...
05/14/2026

What does it take to build something that reaches patients —
not just work in the lab?

That's the question Dr. Marianne van der Steen has spent her career answering.

As a venture builder, founder, and professor operating across Europe and the U.S.,
she's mobilized over €500M to turn breakthrough science into therapies that
actually scale. She's built the ecosystems, the teams, the capital structures —
and done it across borders, across institutions, and across stages of growth.

At the 2026 SoCal TBA Annual Symposium on June 21, she's bringing that
experience into her keynote:

Built to Scale — Winning in Global Life Sciences.

She'll be drawing on her work founding companies, building teams, and the
Harvard Business School Crucell cases to share what leadership in life sciences actually looks like — how to operate across cultures, make decisions under uncertainty, and move innovation from the bench to something that truly scales.

Whether you're still in research or already in the industry,
This is the kind of talk that changes how you think about what's possible.

UCLA CNSI · June 21
Advance rate ends May 20 — 6 days left.

Register

從實驗室的發現，到真正地應用在醫療——中間那段路，要怎麼走？

這是 Dr. Marianne van der Steen 一直想回答的問題。

她跨越歐美兩大洲建立生命科學生態系，動員超過 €500M 資金，
把科學突破轉化為可以規模化的療法。她創辦公司、建立團隊、
橫跨不同文化和機構體系把創新推向市場。

6 月 21 日，她將在 SoCal TBA 年會帶來她的獨到見解，不要錯過這個難得的機會！

📅 UCLA CNSI · 6月21日
🎟 早鳥票 ，5/20截止，剩6天。

報名連結在留言區。

從實驗室出來，第一步要怎麼踏？李冬陽博士 2002 年的答案，沒有人猜得到。台大病理學博士，哈佛醫學院研究員。他選擇回台灣，加入一間當時還在賣保健品的小公司。這個決定後來創造了：・5.3 億美金的授權紀錄・61 億美金市場營收的藥物去年 9...
05/12/2026

從實驗室出來，第一步要怎麼踏？
李冬陽博士 2002 年的答案，沒有人猜得到。
台大病理學博士，哈佛醫學院研究員。
他選擇回台灣，加入一間當時還在賣保健品的小公司。

這個決定後來創造了：
・5.3 億美金的授權紀錄
・61 億美金市場營收的藥物

去年 9 月，李冬陽博士與 SoCal TBA 坐下來聊了這整段歷程。
✨ JBC 論文的商業價值為何能超越《Science》？
✨ 候選藥物如何在大藥廠的專利封鎖下靠科學反敗為勝？
✨ 面對超過 1,000 位投資人，他怎麼撐過來的？

「Science goes where your imagination goes.」

完整對話在會員專屬影片庫 🔐 （請至留言區）

想現場聽下一場這樣的對話？

🗓 6 月 21 日，UCLA CNSI
🎟 早鳥票 5/20 截止

報名連結請見留言區。

Address

San Diego, CA
92122

Website

Alerts

Be the first to know and let us send you an email when SoCal Taiwanese Biotechnology Association - SoCal TBA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to SoCal Taiwanese Biotechnology Association - SoCal TBA:

Shortcuts

Share

Category